期刊文献+

负载5-ALA纳米微球对膀胱癌光动力学作用的初步研究 被引量:3

Effect of 5-ALA derivative-loaded photosensitized nanoparticles photodynamic therapy on bladder cancer T24 cells
下载PDF
导出
摘要 目的探讨负载5-盐酸乙酰氨基丙酸(5-aminolevulinic acid,5-ALA)的光敏感纳米微球的制备方法,并初步研究其在体外对膀胱癌T24细胞的光动力学效应。方法以纳米沉淀法制备光敏感纳米微球,紫外分光光度法检测载药率,动态光散射的方法检测纳米粒径,原子力显微镜观察纳米微球形貌。将膀胱癌T24细胞分别与不同浓度的光敏感纳米微球共同孵育,以能量密度为6 J/cm2,波长为650 nm半导体激光照射。另设空白对照组、空载体组、5-ALA组。以MTT比色法测定T24细胞的生长抑制率。结果光敏感纳米微球载药量为7%,负载效率85%。处理组5、10、25和50μg/ml光敏感纳米微球的细胞生长抑制率分别为73.19%、79.95%、83.86%和89.74%,与空白对照组、空载体组、5-ALA组比较差异有统计学意义(P<0.05)。结论纳米微球负载5-ALA具有理想的载药率,光敏感纳米微球能显著提高光动力学杀伤效应。 Objective To develop a novel 5-ALA (5-aminolevulinic acid) derivative-loaded photosensitized nanoparticles, and to study the effect of photodynamic therapy on bladder cancer T24 cells. Methods Drug-loaded photosensitized nanoparticles were prepared by nanoprecipitation method, using the UV-spectrophotometric method to determine the drug loading content. Mean diameter and size distribution of the prepared nanoparticles were determined by dynamic light scattering. Atomic force microscope was used to study the surface morphology of nanoparticles in a greater detail. At test groups, T24 cells were incubated with different concentrations of photosensitized nanopartieles, and then irradiated by 650nm laser ( 6J/cm^2 ). Additionaly, as control group, there were following ones blank group, nanoparticles and irradiation group, 5-ALA and irradiation group. MTT method was used to detect the growth inhibitory rate of T24 cells. Results The yield of sample was 85% and the drug loading content was 7%. The growth inhibitory rates of 5.0μg/ml, 10. 0μg/ ml, 25. 0μg/ml, 50. 0μg/trd photosensitized nanoparticles were 73.19% ,79. 95% ,83. 86% and 89. 74%, respectively. Compared with them, the difference was statistically significant (P 〈 0. 05 ). Conclusion The drug loading content of 5-ALA derivative-loaded photosensitized nanoparticles was satisfied, and can significantly improve the effect of photodynamic therapy on T24 cells.
出处 《临床肿瘤学杂志》 CAS 2010年第2期132-135,共4页 Chinese Clinical Oncology
基金 江苏省自然科学基金面上项目(BK2008060)
关键词 纳米微球 光动力学疗法 膀胱癌 5-盐酸乙酰氨基丙酸 Nanoparticles Photodynamic therapy Bladder cancer 5-Aminolevulinic acid (5-ALA)
  • 相关文献

参考文献15

  • 1Parekh DJ, Bochner BH, Dalbagni G. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments[ J]. J Ctin Oncol,2006,24:5519 - 5527.
  • 2Dougherty TJ. Photodynamie therapy (PDT) of malignant tumors [J]. Crit Rev Oneol Hematol, 1984,2:83 -116.
  • 3Fotinos N, Campo MA, Popowycz F, et al. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives [ J ]. Photochem Photobiol, 2006,82 : 994 - 1015.
  • 4Kamuhabwa AR, Huygens A, Roskams T, et al. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen cartier, perfluorodecalin [ J ]. Int J Oncol,2006,28:775 - 780.
  • 5Skyrme RJ, French AJ, Datta SN, et al. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma [ J ]. BJU Int ,2005,95 : 1206 - 1210.
  • 6Braathen LR, Szeimies RM, Basset-Seguin N, et al. International Society for Photodynamie Therapy in Dermatology. Guidelines on the use of photodynamie therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005 [ J ]. J Am Acad Dermatol, 2007,56 : 125 - 143.
  • 7Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers[J]. Dermatol Clin,2007,25:5 -14.
  • 8Kehy C J, Brown N J, Reed MW, et al. The use of 5-aminolaevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis[J]. Photochem Photobiol Sci,2002,1:158 - 168.
  • 9Casas A, Batlle A. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy[ J]. Curr Med Chem,2006,13 : 1157 - 1168.
  • 10Fotinos N, Campo MA, Popowycz F, et al. 5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives [ J ]. Photochem Photobiol, 2006, 82:994 -1015.

同被引文献34

  • 1丁军,赵继红,李祎,杨海山.MSPIO可用作临床MRI阴性对比剂的影像学、病理毒理学分析[J].中国实验诊断学,2007,11(3):380-384. 被引量:2
  • 2万正杨.原子吸收光谱法测定鼠肾组织中Cu、Fe、Zn、Ca、Mg[J].中国卫生检验杂志,2007,17(7):1228-1230. 被引量:4
  • 3Dougherty TJ. Studies on the structure of porphyrins contained in photofrin II[J]. Photochem Photobiol' 1987.46 (S) :S69-S73.
  • 4Oleinick N Lv Morris R Lv Belichenko 1. The role of apoptosis in response to photodynamic therapy: what. where. why and how[J]. Photochem Photo biol Sci. 2002.1 (1) : 1-21.
  • 5Ishizuka M. Abe F. Sa no Y. et al. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy [J]. Int Irnrnunopharrnacol , 2011.11 (3) : 358-365.
  • 6Steluti R. De Rosa F S. CollettJ. et al. Topical glycerol monooleate/ propylene glycol formulations enhance 5-aminole?vulinic acid in vitro skin delivery and in vivo protoporphyrin IX accumulation in hairless mouse skin[J]. EurJ Pharm Biopharrn , 2005. 60( 3) : 439-444.
  • 7Kato S.KawamuraJ. Kawada K.et al. Fluorescence diagnosis of metastatic lymph nodes using S-aminolevulinic acid (S-ALA) in a mouse model of colon cancer[J].J Surg Res. 2012.176(2):430-436.
  • 8Casas A. Batlle A. Aminolevulinic acid derivatives and lipo?some delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy[J]. Curr Med Chern , 2006.13(10):1157-1168.
  • 9Fotinos NvCampo M Av Popowycz F.et al. S-Aminolevulinic acid derivatives in photomedicine , characteristics. application and perspectives[J]. Photochem Photobiol , 2006.82 (4) : 994- lOIS.
  • 10Krammer B. Plaetzer K. ALA and its clinical impact. from bench to bedside[J]. Photochem Photobiol Sci. 2008. 7 (3) : 283-289.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部